LENZ Therapeutics, Inc.'s LNZ100 eye drops show strong phase 3 results for presbyopia, outperforming competitors. Click here ...

Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Fearing potential tariffs from President Trump's announcement, some European drugmakers are increasing air shipments of ...

The Japanese Ministry of Health, Labour and Welfare on Thursday approved Genmab A/S’ (NASDAQ:GMAB) Tivdak (tisotumab vedotin) ...

Ironwood Pharmaceuticals, Inc. (the "Company") , a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today ...

Paraganglioma Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Global Panuvei ...

Some drugmakers are taking the unusual step of sending more medicines by air to the U.S., two executives and two logistics ...

Title: ATNM-400 is a novel Actinium-225 antibody radioconjugate with strong efficacy in preclinical models of prostate cancer ...

Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner’s New Drug Application for ARCATUS® (XIPERE®) for Uveitic Macular Edema ...

Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner's New Drug Application for ARCATUS® (XIPERE®) for Uveitic Macular Edema ...